Investors and entrepreneurs are beginning to bring new diagnostic tools to market that promise better results for cancer patients through the identification of mutations in cancer cells that can creat
Through a combination of new sensing technology and machine learning, Cambridge Cancer Genomics has developed a technique that can identify how well cancer treatments are working. That's incredibly im